Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer
Article Details
Authors (26)
Yaoyu Guo
Yi Zhong
Peishan Hu
Yufeng Chen
Power Battery & Systems Research Center, State Key Laboratory of Catalysis
Wenjun Guo
Jianfeng Chen
Peiyong Guan
Zhengran Zhou
Fang Zhu
MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry
Xian Zeng
College of Chemistry and Materials Science, Guangdong Provincial Key Laboratory of Supramolecular Coordination Chemistry
Jiuping Gao
Qiqing Xiong
Zhaoliang Yu
Chuling Hu
Zerong Cai
Department of Molecular and Cell Biology, University of California Berkeley
Xiaoyu Xie
Department of Anesthesiology, West China Hospital, Sichuan University
Jing Han Hong
Jason Yongsheng Chan
Wenyu Wang
Department of Pharmaceutics, School of Pharmacy
Dechang Diao
Xiaojun Xia
Qiang Yu
Choon Kiat Ong
Yijun Gao
Key Laboratory of Biomedical Polymers Ministry of Education, College of Chemistry and Molecular Sciences
Xiaojian Wu
Jing Tan